Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Urinary Incontinence - Pipeline Insight, 2024
... picture of the Urinary Incontinence pipeline landscape is provided, which includes the disease overview and Urinary Incontinence treatment guidelines. The assessment part of the report embraces in-depth Urinary Incontinence commercial assessment and clinical assessment of ... Read More
-
Usher Syndrome Type 2 - Pipeline Insight, 2024
... the Usher Syndrome Type 2 market. A detailed picture of the Usher Syndrome Type 2 pipeline landscape is provided, which includes the disease overview and Usher Syndrome Type 2 treatment guidelines. The assessment part of ... Read More
-
Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034
... these cases are going to increase because of changes in psychosocial and physical work demands, risk factors for LBP (2023–2034). According to DelveInsight’s analysis, the total number of diagnosed prevalent cases of CLBP in the ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034
... and these cases are going to increase during the forecast period (2023–2034). This increase in growth can be attributed to growing awareness, ultimately leading to an increase in the diagnosed prevalence of FECD. According to ... Read More
-
Abdominal Aneurysms - Pipeline Insight, 2024
... picture of the Abdominal Aneurysms pipeline landscape is provided, which includes the disease overview and Abdominal Aneurysms treatment guidelines. The assessment part of the report embraces in-depth Abdominal Aneurysms commercial assessment and clinical assessment of ... Read More
-
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024
... the Acquired Immunodeficiency Syndrome (AIDS) market. A detailed picture of the Acquired Immunodeficiency Syndrome (AIDS) pipeline landscape is provided, which includes the disease overview and Acquired Immunodeficiency Syndrome (AIDS) treatment guidelines. The assessment part of ... Read More
-
Acute pancreatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Anti-obesity Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 4.51 billion in 2023, and the market is now projected to grow from USD 6.15 billion in 2024 to USD 37.94 billion by 2032, exhibiting a CAGR of 25.5% during the forecast period of 2024-2032. ... Read More
-
Acid sphingomyelinase deficiency (ASMD) - Pipeline Insight, 2024
... the Acid sphingomyelinase deficiency (ASMD) market. A detailed picture of the Acid sphingomyelinase deficiency (ASMD) pipeline landscape is provided, which includes the disease overview and Acid sphingomyelinase deficiency (ASMD) treatment guidelines. The assessment part of ... Read More
-
Abscess - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Abscess treatment guidelines. The assessment part of the report embraces in-depth Abscess commercial assessment and clinical assessment of the Abscess pipeline products from the pre-clinical ... Read More
-
Acute Lung Injury - Pipeline Insight, 2024
... Injury market. A detailed picture of the Acute Lung Injury pipeline landscape is provided, which includes the disease overview and Acute Lung Injury treatment guidelines. The assessment part of the report embraces in-depth Acute Lung ... Read More
-
Acute Unilateral Vestibulopathy (AUV) - Pipeline Insight, 2024
... the Acute Unilateral Vestibulopathy (AUV) market. A detailed picture of the Acute Unilateral Vestibulopathy (AUV) pipeline landscape is provided, which includes the disease overview and Acute Unilateral Vestibulopathy (AUV) treatment guidelines. The assessment part of ... Read More
-
Acute Muscle Injuries - Pipeline Insight, 2024
... Injuries market. A detailed picture of the Acute Muscle Injuries pipeline landscape is provided, which includes the disease overview and Acute Muscle Injuries treatment guidelines. The assessment part of the report embraces in-depth Acute Muscle ... Read More
-
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024
... the Acute Myelogenous Leukemia (AML) market. A detailed picture of the Acute Myelogenous Leukemia (AML) pipeline landscape is provided, which includes the disease overview and Acute Myelogenous Leukemia (AML) treatment guidelines. The assessment part of ... Read More
-
Acute Pyelonephritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Gouty Arthritis (Gout) - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Prader-Willi Syndrome - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Growth Hormone (GH) Agonist - Pipeline Insight, 2024
... (GH) Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2024
... and growth prospects across Caspase 3 (CPP32, Apopain or YAMA) Activators development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline ... Read More
-
Alpha Glucosidase Inhibitor - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Alpha Receptor Antagonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Alpha-1 Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2024
... prospects across Alpha v Beta 5 Integrin Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental ... Read More
-
Alpha-2 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Alternating Hemiplegia of Childhood (AHC) - Pipeline Insight, 2024
... growth prospects across the Alternating Hemiplegia of Childhood (AHC) market. A detailed picture of the Alternating Hemiplegia of Childhood (AHC) pipeline landscape is provided, which includes the disease overview and Alternating Hemiplegia of Childhood (AHC) ... Read More
Research Assistance
